Depression continues to be one of the most difficult targets in drug development. But researchers at the RIKEN Brain Science Institute say they were able to link a mutation with mitochondrial dysfunction that appeared to spur depression-like symptoms in mice. And their work points to a part of the brain--the paraventricular thalamus--which they say has never before been tied to depression. Release